Lv1
38 积分 2023-10-26 加入
TROP2 expression and SN38 antitumor activity in malignant pleural mesothelioma cells provide a rationale for antibody-drug conjugate therapy
2个月前
已完结
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
2个月前
已完结
An oncolytic virus-T cell chimera for cancer immunotherapy
3个月前
已完结
Efficient in vivo generation of CAR T cells using a retargeted fourth-generation lentiviral vector
3个月前
已完结
Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients
3个月前
已完结
In vivo FAP-CAR macrophages enhance chemotherapy and immunotherapy against pancreatic cancer by removing the fibrosis barrier
6个月前
已完结
Dual targeting chimeric antigen receptor cells enhance antitumour activity by overcoming T cell exhaustion in pancreatic cancer
6个月前
已完结
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual targeting antibody overcome antigen heterogeneity in AML
6个月前
已完结
Bispecific killer cell engager-secreting CAR-T cells redirect natural killer specificity to enhance antitumour responses
6个月前
已完结
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML
6个月前
已完结
皖公网安备34019202002308
